Details of the Drug Reposition

General Information of This Drug (ID: DM0GUV2)

Drug Name
DE-766   DM0GUV2

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastric adenocarcinoma DISWWLTC 2B72 Phase 3 [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 3 [1]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Nasopharyngeal carcinoma DISAOTQ0 2B6B Investigative [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Daiichi Sankyo.
2 Nasopharyngeal carcinoma: Current treatment options and future directions. J Nasopharyng Carcinoma, 2014, 1(16): e16.